"Cell Engineering" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods and techniques used to modify or select cells and develop conditions for growing cells for biosynthetic production of molecules (METABOLIC ENGINEERING), for generation of tissue structures and organs in vitro (TISSUE ENGINEERING), or for other BIOENGINEERING research objectives.
| Descriptor ID |
D060846
|
| MeSH Number(s) |
E05.481.500.311 J01.293.069.249
|
| Concept/Terms |
Cell Engineering- Cell Engineering
- Engineering, Cell
- Cellular Engineering
- Engineering, Cellular
|
Below are MeSH descriptors whose meaning is more general than "Cell Engineering".
Below are MeSH descriptors whose meaning is more specific than "Cell Engineering".
This graph shows the total number of publications written about "Cell Engineering" by people in this website by year, and whether "Cell Engineering" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2020 | 2 | 0 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Engineering" by people in Profiles.
-
Splendid isolation. Blood. 2023 06 01; 141(22):2665-2666.
-
Transgenic CD8a? co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells. J Immunother Cancer. 2020 11; 8(2).
-
Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nat Biotechnol. 2021 01; 39(1):56-63.
-
Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities. Expert Opin Biol Ther. 2018 06; 18(6):653-664.
-
Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo. Nat Commun. 2018 04 10; 9(1):1325.
-
Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line. Biotechnol J. 2018 Feb; 13(2).
-
Improving the safety of T-Cell therapies using an inducible caspase-9 gene. Exp Hematol. 2016 Nov; 44(11):1013-1019.
-
Biological approaches to treating intervertebral disk degeneration: devising stem cell therapies. Cell Transplant. 2015; 24(11):2197-208.
-
Engineered T cells for cancer treatment. Cytotherapy. 2014 Jun; 16(6):713-33.
-
Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy. Stem Cells. 2013 Feb; 31(2):227-35.